Terms: = Brain cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
37 results:
1. Insights into the roles of non-coding RNAs and angiogenesis in glioblastoma: An overview of current research and future perspectives.
Song Z; Xue Z; Wang Y; Imran M; Assiri M; Fahad S
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130567. PubMed ID: 38242182
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
[TBL] [Abstract] [Full Text] [Related]
3. Haplotype-GGGT in long non-coding RNA malat1 inhibits brain metastatic lung cancer and lymph nodes of lung cancer via the malat1/miR-328/KATNB1.
Liu T; Ma J; Hou D; Wang W; Cao H
Aging (Albany NY); 2023 Mar; 15(6):1918-1930. PubMed ID: 36934373
[TBL] [Abstract] [Full Text] [Related]
4. The role of lncRNAs/miRNAs/Sirt1 axis in myocardial and cerebral injury.
Barangi S; Hayes AW; Karimi G
Cell Cycle; 2023 May; 22(9):1062-1073. PubMed ID: 36703306
[TBL] [Abstract] [Full Text] [Related]
5. Influence of the Cultivation Conditions of the Glioblastoma Neurosphere on the Expression of malat1 and LINCROR Long Non-coding RNA Genes.
Mazur DV; Mishanova AV; Kovalenko TF; Shakhparonov MI; Antipova NV
Dokl Biochem Biophys; 2023 Feb; 508(1):21-24. PubMed ID: 36653583
[TBL] [Abstract] [Full Text] [Related]
6. brain atlas for glycoprotein hormone receptors at single-transcript level.
Ryu V; Gumerova A; Korkmaz F; Kang SS; Katsel P; Miyashita S; Kannangara H; Cullen L; Chan P; Kuo T; Padilla A; Sultana F; Wizman SA; Kramskiy N; Zaidi S; Kim SM; New MI; Rosen CJ; Goosens KA; Frolinger T; Haroutunian V; Ye K; Lizneva D; Davies TF; Yuen T; Zaidi M
Elife; 2022 Sep; 11():. PubMed ID: 36052994
[TBL] [Abstract] [Full Text] [Related]
7. The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells.
Vazifehmand R; Ali DS; Othman Z; Chau DM; Stanslas J; Shafa M; Sekawi Z
J Neurovirol; 2022 Dec; 28(4-6):566-582. PubMed ID: 35951174
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA-malat1 Regulates cancer Glucose Metabolism in Prostate cancer via MYBL2/mTOR Axis.
Mu X; Shen Z; Lin Y; Xiao J; Xia K; Xu C; Chen B; Shi R; Zhu A; Sun X; Tao T; Song X; Xuan Q
Oxid Med Cell Longev; 2022; 2022():8693259. PubMed ID: 35557985
[TBL] [Abstract] [Full Text] [Related]
9. Long non-coding RNA panel as a molecular biomarker in glioma.
Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
[TBL] [Abstract] [Full Text] [Related]
10. cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNAs as a predictive markers of group 3 medulloblastomas.
Mutlu M; Tekin C; Ak Aksoy S; Taskapilioglu MO; Kaya S; Balcin RN; Ocak PE; Kocaeli H; Bekar A; Tolunay S; Tunca B
Neurol Res; 2022 Mar; 44(3):232-241. PubMed ID: 34533098
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA malat1 promotes glioma cell growth through sponge miR-613.
Su Y; Liang C; Yang Q
J BUON; 2021; 26(3):984-991. PubMed ID: 34268963
[TBL] [Abstract] [Full Text] [Related]
13. Coexistence of TERT C228T mutation and malat1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets.
Ak Aksoy S; Mutlu M; Tunca B; Kocaeli H; Taskapilioglu MO; Bekar A; Tekin C; Argadal OG; Civan MN; Kaya İS; Ocak PE; Tolunay S
Neurol Res; 2021 Nov; 43(11):916-925. PubMed ID: 34210246
[No Abstract] [Full Text] [Related]
14. METTL3 enhances the stability of malat1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract] [Full Text] [Related]
15. Barcoded oligonucleotides ligated on RNA amplified for multiplexed and parallel in situ analyses.
Liu S; Punthambaker S; Iyer EPR; Ferrante T; Goodwin D; Fürth D; Pawlowski AC; Jindal K; Tam JM; Mifflin L; Alon S; Sinha A; Wassie AT; Chen F; Cheng A; Willocq V; Meyer K; Ling KH; Camplisson CK; Kohman RE; Aach J; Lee JH; Yankner BA; Boyden ES; Church GM
Nucleic Acids Res; 2021 Jun; 49(10):e58. PubMed ID: 33693773
[TBL] [Abstract] [Full Text] [Related]
16. Long Non-coding RNA malat1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124.
Cheng H; Zhao H; Xiao X; Huang Q; Zeng W; Tian B; Ma T; Lu D; Jin Y; Li Y
Mol Neurobiol; 2021 Mar; 58(3):1006-1016. PubMed ID: 33078370
[TBL] [Abstract] [Full Text] [Related]
17. Long non-coding RNAs as epigenetic mediator and predictor of glioma progression, invasiveness, and prognosis.
Zhang Y; Xiao Y; Li GC; Gong FY; Zhang XN; Hou K
Semin Cancer Biol; 2022 Aug; 83():536-542. PubMed ID: 32920124
[TBL] [Abstract] [Full Text] [Related]
18. Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers.
Maruyama R; Yokota T
Methods Mol Biol; 2020; 2176():49-56. PubMed ID: 32865781
[TBL] [Abstract] [Full Text] [Related]
19. Exercise-mediated downregulation of malat1 expression and implications in primary and secondary cancer prevention.
Paronetto MP; Dimauro I; Grazioli E; Palombo R; Guidotti F; Fantini C; Sgrò P; De Francesco D; Di Luigi L; Capranica L; Caporossi D
Free Radic Biol Med; 2020 Nov; 160():28-39. PubMed ID: 32768573
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNA malat1 as a key target in pathogenesis of glioblastoma. Janus faces or Achilles' heal?
Baspinar Y; Elmaci I; Ozpinar A; Altinoz MA
Gene; 2020 May; 739():144518. PubMed ID: 32119915
[TBL] [Abstract] [Full Text] [Related]
[Next]
